Cell Transplant is a procedure in which cells, often stem cells or cells that can be induced to become pluripotent stem cells, are transferred to a site where the tissue is damaged or diseased. The transfer can occur within an individual (autologous transplantation), between individuals, or between species.
This report contains market size and forecasts of Cell Transplant in Global, including the following market information:
Global Cell Transplant Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cell Transplant market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Peripheral Blood Stem Cells Transplant (PBSCT) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cell Transplant include Regen Biopharma, Global Cord Blood Corporation, CBR Systems, Escape Therapeutics, Cryo-Save, Lonza Group, Pluristem Therapeutics and Stemedica Cell Technology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cell Transplant companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell Transplant Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cell Transplant Market Segment Percentages, by Type, 2021 (%)
Peripheral Blood Stem Cells Transplant (PBSCT)
Bone Marrow Transplant (BMT)
Cord Blood Transplant (CBT)
Global Cell Transplant Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cell Transplant Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Cell Transplant Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cell Transplant Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell Transplant revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cell Transplant revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Regen Biopharma
Global Cord Blood Corporation
CBR Systems
Escape Therapeutics
Cryo-Save
Lonza Group
Pluristem Therapeutics
Stemedica Cell Technology